NCT07045688View on ClinicalTrials.gov

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

November 25, 2025

Study Completion Date

November 25, 2025

Conditions
H. Pylori Infection
Interventions
DRUG

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

DRUG

Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

DRUG

Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Trial Locations (1)

Unknown

RECRUITING

Sohag University Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER